AGIBOT WORLD CHALLENGE 2026 Advances Embodied AI Competition from Simulation to Real-Robot Testing at ICRA 2026
VIENNA, June 5, 2026 /PRNewswire/ -- AGIBOT, a leading embodied AI company, hosted AGIBOT WORLD CHALLENGE 2026 alongside ICRA 2026 in Vienna, bringing together 526 research and enterprise teams from 27 countries to compete across two embodied AI...
Early Data Show Highly Selective FGFR2 Inhibitor 3HP-2827 Active in Advanced CCA; Chinese Academy of Sciences' Zhou Jian Comments on Potential for Patients With FGFR2 Alterations
CHICAGO, June 2, 2026 /PRNewswire/ -- At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, 3H Pharmaceuticals released new clinical data for its wholly owned candidate, 3HP-2827. The ongoing study focuses on patients with...
Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
High Impact Session presented at Heart Rhythm Society's Congress in Chicago First time showing results of new Less Invasive approach Improvement in Left Ventricular Ejection Fraction (LVEF), 6 Minute Walk Test (6MWT), Quality of Life (QOL) and New...
Co-PSMA: Cu-64 SAR-bisPSMA more than doubled prostate cancer lesion and patient detection vs. Ga-68 PSMA-11 in head-to-head trial
HIGHLIGHTS Abstract outlining key findings from the Co-PSMA Investigator-Initiated Trial (IIT) has been released. The study was led by Prof Louise Emmett at St Vincent's Hospital Sydney, and the abstract was accepted for oral presentation at the...
ValueLabs to Continue Growth Journey as an Independent, Founder-Led Company
HYDERABAD, India, Jan. 15, 2026 /PRNewswire/ -- ValueLabs, a global digital engineering and enterprise AI company, today announced that it will continue its growth journey as an independent, founder-led organization following the completion of a...
AV-Comparatives Releases Consumer Summary Report 2025
Independent Testing Highlights Top-Performing Consumer Security Solutions INNSBRUCK, Austria, Jan. 15, 2026 /PRNewswire/ -- AV-Comparatives, the internationally recognised independent authority in cybersecurity testing, has published its Consumer...
Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC "Blockbuster" Therapy
TAIPEI and SAN DIEGO, Dec. 29, 2025 /PRNewswire/ -- Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging field of...
CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596
SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that it has submitted two separate Investigational New Drug (IND)...
Z.ai Releases GLM-4.7 Designed for Real-World Development Environments, Cementing Itself as "China's OpenAI"
BEIJING, Dec. 27, 2025 /PRNewswire/ -- On December 22, Z.ai released GLM-4.7, the latest iteration of its GLM large language model family. Designed to handle multi-step tasks in production, GLM-4.7 targets development environments that involve...
China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite instability-high or mismatch repair deficient (MSI-H/dMMR)...